Cambridge Antibody - Acquisition, etc.
16 July 1998 - 6:42PM
UK Regulatory
RNS No 3885q
CAMBRIDGE ANTIBODY TECHNOLOGY
16th July 1998
ACQUISITION OF APTEIN INC. CLOSED
&
APPROVAL OF EUROPEAN PATENT FOR POLYSOME DISPLAY RECEIVED
Melbourn, UK: Cambridge Antibody Technology Group plc (CAT) today announces
that it has closed the deal for the purchase of US company, Aptein Inc. and in
addition Aptein's European patent for its polysome display technology was
granted on 15 July 1998.
The purchase of this US Company, announced on 23 June 1998, provides CAT with
a powerful extension to its existing antibody display technology. Aptein now
has granted US, European and Australian patents which dominate the field of
polysome display.
For Further Information Contact:
Cambridge Antibody Technology Group Plc
Dr David Chiswell, Chief Executive Officer Tel: +44 (0) 1763 203233
City/Financial Enquiries
HCC.DeFacto, Nicola How Tel: +44 (0) 171 496 3300
Trade/Scientific Press Enquiries
HCC.DeFacto, Andrew Worsfold Tel: +44 (0) 1223 518093
END
ACQDQFBFVDKZBKD
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024